RESEARCH-USE BIOSIMILAR ANTIBODY
Simaravibart
Monoclonal antibody · IgG1
Simaravibart (MAD-0004J08) is an IgG1κ antibody targeting the SARS-CoV2 spike (S) glycoprotein receptor binding domain.
TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-166
CATALOG NUMBERSC-BS-166
MOLECULAR WEIGHTApprox. 144.955 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Simaravibart (MAD-0004J08) is an IgG1κ antibody targeting the SARS-CoV2 spike (S) glycoprotein receptor binding domain.
Simaravibart is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.